| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 93957-54-1 | 氟伐他汀; 7-[3-(4-氟苯基)-1-(1-甲基乙基)-1H-吲哚-2-基]-3,5-二羥基-6-庚烯酸 | Fluvastatin; 7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid |  | C24H26FNO4 | 詳情 | 供應(yīng)商 |
| 143201-11-0 | 西立伐他汀鈉; (+)-(3R,5S,6E)-7-[4-(4-氟苯基)-2,6-二異丙基-5-甲氧甲基-吡啶-3-基]-3,5-二羥基-6-庚烯酸單 | Cerivastatin sodium; Sodium 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate |  | C26H33FNNaO5 | 詳情 | 供應(yīng)商 |
| 194934-95-7 | (E)-5-羥基-3-氧代-7-[3'-(4''-氟苯基)-1'-(1''-甲基乙基)吲哚-2'-基]-6-庚烯酸叔丁酯 | -; 6-Heptenoicacid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-,1,1-dimethylethyl ester, [S-(E)]- |  | C28H32FNO4 | 詳情 | 供應(yīng)商 |
| 194934-96-8 | 氟伐他汀中間體; (E)-3,5-二羥基-7-[3'-(4''-氟苯基)-1'-(1''-甲基乙基)吲哚-2'-基]-6-庚烯酸叔丁酯 | -; 6-Heptenoicacid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,1,1-dimethylethyl ester, [S-[R*,S*-(E)]]- |  | C28H34FNO4 | 詳情 | 供應(yīng)商 |
| 98672-91-4 | 1S-[1Α,2Β(5Z),3Β,4Α]]-7-[3-[2-(苯氨基甲酰基)肼基甲基]-7-氧代雙環(huán)[2.2.1]庚-2-基]-5-庚烯酸 | SQ 29,548 (POTENT AND SPECIFIC THROMBOXA NE A2 RECEPT; SQ 29,548 (POTENT AND SPECIFIC THROMBOXA NE A2 RECEPT; (Z)-7-[(1R,4S)-3α-[[2-[(Phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1]heptan-2α-yl]-5-heptenoic acid; BMS-18290; 1S-[1α,2β(5Z),3β,4α]]-7-[3-[2-(Phenylcarbamoyl)hydrazinomethyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid | 無 | C21H29N3O4 | 詳情 | 供應(yīng)商 |
| 877674-77-6 | 7-氯-2-[[[(1S)-2,2-二甲基環(huán)丙基]羰基]氨基]-2-庚烯酸; 7-氯-2-[[[(1S)-2,2-二甲基環(huán)丙基]羰基]氨基]-2-庚? | 7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid |  | C13H20ClNO3 | 詳情 | 供應(yīng)商 |
| 180973-24-4 | (3S,4E)-3-羥基-7-[(三苯基甲基)硫基]-4-庚烯酸; (3S,4E)-3-羥基-7-[(三苯基甲基)硫基]-4-庚烯酸 | (3S,4E)-3-Hydroxy-7-[(triphenylmethyl)thio]-4-heptenoic acid; (3S,4E)-3-Hydroxy-7-[(triphenylmethyl)thio]-4-heptenoic acid; (S,E)-3-hydroxy-7-(tritylthio)hept-4-enoic acid |  | C26H26O3S | 詳情 | 供應(yīng)商 |
| 59619-81-7 | (5Z)-7-[(1R,2R,3R,5S)-3,5-二羥基-2-[(1E)-2-[2-(苯氧基甲基)-1,3-二氧環(huán)戊-2-基]乙烯基]環(huán)戊基]-5-庚烯酸; (5Z)-7-[(1R,2R,3R,5S)-3,5-二羥基-2-[(1E)-2-[2-(苯氧基甲基)-1,3-二氧環(huán)戊-2-基]乙烯基]環(huán)戊基]-5-庚烯酸; 依替前列酮; 依替前列通; 依替前列素 | Etiproston; 5-Heptenoic acid, 7-(1R,2R,3R,5S)-3,5-dihydroxy-2-(1E)-2-2-(phenoxymethyl)-1,3-dioxolan-2-ylethenylcyclopentyl-, (5Z)-; (Z)-7-[(1R)-3α,5α-Dihydroxy-2β-[(E)-2-(2-phenoxymethyl-1,3-dioxolan-2-yl)ethenyl]cyclopentan-1α-yl]-5-heptenoic acid; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-5-heptenoic acid; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-2-[2-(phenoxymethyl)-1,3-dioxolane-2-yl]ethenyl]cyclopentyl]-5-heptenoic acid; Etiprostone; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-5-heptenoic acid; Etiproston |  | C24H32O7 | 詳情 | 供應(yīng)商 |
| 288617-73-2 | (2R)-2-N-芴甲氧羰基氨基-2-甲基-6-庚烯酸 | (S)-N-Fmoc-α-(4-Pentenyl)Alanine; (S)-N-Fmoc-α-4-n-pentenylalanine, Fmoc-(S)-2-(4-pentenyl)alanine, Fmoc-(S)-2-amino-2-methyl-hept-6-enoic acid | 無 | C23H25NO4 | 詳情 | 供應(yīng)商 |